Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL SINGLE-USE BIOPROCESSING MARKET IS EXPECTED TO REACH USD 26.54 BILLION BY 2028 FROM USD 9 BILLION IN 2022, GROWING AT A CAGR OF 19.74% DURING THE FORECAST PERIOD.
The Single-use Bioprocessing Market Size, Share, & Trends Analysis Report by
- Product Type: Single-use Bioprocessing Equipment and Simple & Peripheral Devices
- Application: Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, and Others
- End-users: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), and R&D Companies & Research Institutes
- Method: Filtration, Storage & Transport, Cell Culture, Mixing, and Purification
- Workflow: Upstream and Downstream
- Geography:North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
SINGLE-USE BIOPROCESSING MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2028) | USD 26.54 Billion |
| Market Size (2022) | USD 9 Billion |
| CAGR (2022-2028) | 19.74% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Product Type, Application, End-users, Method, Workflow, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Thermo Fisher Scientific, Sartorius Stedim Biotech, Danaher, Merck KGaA, and Avantor |
MARKET OUTLOOK
The global single-use bioprocessing market was valued at USD 9.00 billion in 2022 and is expected to reach USD 26.54 billion by 2028, growing at a CAGR of 19.74%. The growth of new therapeutic modalities, such as cell and gene therapy and antibody-drug conjugates, is increasing the demand for single-use solutions. This has also led suppliers to launch new single-use products to meet the specific needs of these modalities. Thereby driving the expansion of single-use products and the growth of the single-use bioprocessing market.
Single-use bioprocessing is essential and significant in the production of biopharmaceuticals. All active pharmaceutical ingredients must be sterile for administration. Therefore, it should be prepared under sterile conditions. Compared to single-use systems, traditional production using stainless steel equipment is typically more expensive, requiring higher maintenance for reuse and higher operating costs over several years. Moreover, a disadvantage of manufacturing processes based on stainless steel equipment is their low flexibility (i.e., production lines dedicated to individual products or manufacturing steps) and the significant amount of time and effort required to ensure equipment is ready. This includes cleaning-in-place (CIP) and sterilization-in-place (SIP) procedures and final validation of repurposed bioprocess equipment, which consumes time and resources.
Single-use equipment is bound to revolutionize the vast majority of biomanufacturing process steps in the facilities of biopharmaceutical companies. There is high potential in making processes more cost-effective due to simplifying and customizing several aspects of bioprocessing technology and reducing cost-of-goods. Over the past decade, the single-use bioprocessing market has witnessed the entry of several single-use bioprocessing products. Their usage in biopharmaceutical development and manufacturing processes has continued to increase steadily over the past few years. Currently, end-users can choose from a diverse range of SUB products from global and local suppliers. Most SUB products are used in research, clinical production, and manufacturing facilities, where a broad range of biologics are produced. With the availability of single-use bioreactors, connectors, mixers, bioprocessing containers, sampling and transfer systems, sensors, single-use pumps, and other SUB products, end-users can fully adopt SUB, especially in upstream bioprocessing applications.
The increasing usage of single-use products in upstream bioprocessing applications led to the development of innovative single-use products for downstream bioprocessing, especially chromatography columns and membrane adsorbers. However, scalability and high cost are major challenges for using single-use products in downstream bioprocessing, especially for purification bioprocessing.
When handled and used appropriately, SUB products offer safer and faster development and manufacturing of biopharmaceuticals. Owing to their numerous advantages, several biopharmaceutical manufacturers and CMOs are investing significant capital in establishing single-use bioprocessing manufacturing facilities. For instance, major pharma and biotech companies such as AbbVie, Baxter, Boehringer Ingelheim, F. Hoffmann-La Roche, Merck KGaA, Novartis, Teva Pharmaceutical Industries, Sanofi, and Pfizer and CMOs such as Catalent, Patheon, Lonza, and Rentschler Biopharma are major end-users that adopted single-use bioprocessing in their manufacturing facilities.
MARKET TRENDS & DRIVERS
New Product Launches
Technological advances have been key in introducing new single-use bioprocess consumables worldwide. Players in the single-use bioprocessing market have launched new products that make single-use bioprocessing safer, easier, and more efficient than ever before. Such factors have allowed companies to gain market share by meeting market demands. Market participants apply for patents on single-use disposable bioprocessing products that protect novel designs. The increasing availability of single-use technology for production applications and the launch of new products creates an environment where companies can quickly and easily adopt the technology and begin reaping the benefits. Companies can now reduce costs and improve efficiency in their production processes by replacing traditional, labor-intensive methods with single-use technology.
Increasing Strategic Acquisitions and Collaborations
The strategic acquisition of single-use technology can enhance adoption across biopharmaceuticals. Single-use technology is a cost-effective and efficient way to streamline operations, reduce waste, and improve quality control. By strategically acquiring high-quality single-use technology, organizations can increase their competitive advantage while reducing costs and increasing efficiency. The strategic acquisition of single-use technology can increase the visibility and control of processes, resulting in increased transparency and compliance with industry regulations. The strategic acquisition of single-use technology can be a powerful tool for organizations looking to reduce costs, increase efficiency, and improve their competitive advantage. In addition, the industry players are adopting partnership strategies to facilitate access to local single-use bioprocessing markets.
Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars
The growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars drive the single-use bioprocessing market. Single-use bioprocessing provides a valuable platform for producing biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars. With advances in biomanufacturing, single-use bioprocessing offers greater flexibility, shorter process times, improved scalability, lower capital costs, and reduced product contamination risks. Additionally, single-use bioprocessing eliminates the need for extensive cleaning and sterilization of equipment, thus reducing operational costs.
Growing demand for biopharmaceuticals and biosimilars, driven by aging populations and heightened focus on quality healthcare, is driving increased biomanufacturing capacity. Additionally, the emergence of new technologies and the cost advantages of single-use bioprocessing solutions has increased their utilization and uptake. Therefore, it is expected that the growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars will continue to drive the single-use bioprocessing market in the future.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry. This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing. This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.
INSIGHTS BY APPLICATION
The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others. Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs. Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.
INSIGHTS BY END-USER
The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market. This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing. However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.
INSIGHTS BY METHOD
The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry. It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.
INSIGHTS BY WORKFLOW
The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest. Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies a more efficient and cost-effective workflow.
GEOGRAPHICAL ANALYSIS
The single-use bioprocessing market in North America is growing significantly and is expected to grow at a similar pace during the forecast period. Increasing demand for biologics from patients, especially the elderly, high investments in R&D activities by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the single-use bioprocessing market in North America. North America, especially the U.S., is known for its in-house biopharmaceutical manufacturing facilities, which have bolstered the adoption of disposables (simple and peripheral devices) and highly advanced single-use systems such as mixing systems, bioreactors, and cell culture systems over the past few years. This has allowed the region, especially the U.S., to account for the dominant share in the global single-use bioprocessing market. The availability of the well-established bioprocessing/biomanufacturing landscape and the presence of many leading vendors in this region have also contributed to its dominant market share.
VENDOR LANDSCAPE
The global single-use bioprocessing market is highly dynamic and offers significant growth opportunities for vendors. Although the industry is characterized by the presence of several global as well as local players, a few major global players hold significant shares, offering a broad range of SUTs. As the market offers tremendous growth opportunities, new players are expected to enter, intensifying the competition. Rising competition among SUT manufacturers is expected to drive significant product development, such as providing single-use bioreactors with large manufacturing volumes and capacities.
Avantor, Danaher, Merck KGaA, Sartorius Stedim Biotech, and Thermo Fisher Scientific are the leading players in the global single-use bioprocessing market. Key players specifically focus on the M&A strategy to strengthen their position in the market. In recent years, the market has witnessed major players acquiring several small and medium-sized companies to enhance their product portfolio, strengthen their market presence, and enter the single-use bioprocessing market. One of the recent investment activities in the market includes: in 2021, Merck announced European expansion plans for single-use products critical to manufacturing vaccines and lifesaving therapies. With the USD 27 million investment, the company is enhancing its European expansion plans for this key technology, which produces COVID-19 vaccines and other lifesaving therapies.
Frequently Asked Questions
How big is the global single-use bioprocessing market?
What is the growth rate of the single-use bioprocessing market?
What are the rising trends in the single-use bioprocessing market?
Which region holds the most significant global single-use bioprocessing market share?
Who are the key players in the global single-use bioprocessing market?
The global single-use bioprocessing market size is expected to grow at a CAGR of approximately 19.74% from 2022 to 2028.
The following factors are likely to contribute to the growth of the global single-use bioprocessing market during the forecast period:
- Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars
- Lower Capital Investment in SUTs over Multi-use Platforms and Less Floor Space Requirements
- Increased Acceptance of SUS To Enhance Biomanufacturing Productivity and Efficiency
- Reduced Water Consumption and Lesser Environmental Impact of Single-Use Technologies
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the global single-use bioprocessing market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Thermo Fisher Scientific
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Sartorius Stedim Biotech
- Danaher
- Merck KGaA
- Avantor
Other Prominent Vendors
- 3i Group
- Business Overview
- Product Offerings
- 3M
- ABEC
- Adolf Kühner
- AdvantaPure
- Barry-Wehmiller Companies
- Broadley-James
- Celltainer Biotech
- CerCell A/S
- CESCO Bioengineering
- Charter Medical
- Colder Products Company
- Corning
- Distek
- DrM, Dr. Mueller
- Emerson Electric
- Entegris
- Eppendorf
- Foxx Life Sciences
- Getinge
- HIGH PURITY NEW ENGLAND
- Holland Applied Technologies
- Lonza
- MEISSNER FILTRATION PRODUCTS
- New Horizon Biotech
- OmniBRx Biotechnologies
- PARKER HANNIFIN
- PendoTECH
- PBS Biotech
- Repligen
- Saint-Gobain
- Sentinel Process Systems
- Solaris Biotechnology
- SYSBIOTECH GmbH
- Watson-Marlow Fluid Technology Solutions
- Weigao Group
- W.L. Gore & Associates
Segmentation by Product Type
- Single-use Bioprocessing Equipment
- Simple & Peripheral Devices
Segmentation by Application
- Monoclonal Antibodies (mABs)
- Vaccines
- Cell Therapies
- Others
Segmentation by End-users
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
- R&D Companies & Research Institutes
Segmentation by Method
- Filtration
- Storage & Transport
- Cell Culture
- Mixing
- Purification
Segmentation by Workflow
- Upstream
- Downstream
Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Switzerland
- The U.K.
- Italy
- Spain
- APAC
- China
- Japan
- Australia
- South Korea
- India
- Latin America
- Brazil
- Mexico
- Colombia
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- South Africa
EXHIBIT 1 SEGMENTATION OF GLOBAL SINGLE-USE BIOPROCESSING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH (2022)
EXHIBIT 3 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY: MARKET SHARE 2022–2028 (%)
EXHIBIT 4 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE: MARKET SHARE 2022–2028 (%)
EXHIBIT 5 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION: MARKET SHARE 2022–2028 (%)
EXHIBIT 6 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER: MARKET SHARE 2022–2028 (%)
EXHIBIT 7 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD: MARKET SHARE 2022–2028 (%)
EXHIBIT 8 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW: MARKET SHARE 2022–2028 (%)
EXHIBIT 9 ADVANTAGES OF SINGLE-USE BIOPROCESSING SOLUTIONS IN BIOPHARMACEUTICALS PRODUCTION
EXHIBIT 10 IMPACT OF SINGLE-USE TECHNOLOGY IN CELL AND GENE THERAPY
EXHIBIT 11 BENEFITS OF ADOPTING SUTS
EXHIBIT 12 IMPACT OF INCREASING DEMAND FOR CONTINUOUS BIOPROCESSING
EXHIBIT 13 TRENDS MAKING CONTINUOUS BIOPROCESSING ATTRACTIVE
EXHIBIT 14 IMPACT OF TECHNOLOGICAL ADVANCES IN SINGLE-USE BIOPROCESSING (SUB)
EXHIBIT 15 IMPACT OF NEW PRODUCT LAUNCHES
EXHIBIT 16 IMPACT OF INCREASING STRATEGIC ACQUISITIONS AND COLLABORATIONS
EXHIBIT 17 IMPACT OF GROWING BIOMANUFACTURING CAPACITY AND UPTAKE OF BIOPHARMACEUTICALS & BIOSIMILARS
EXHIBIT 18 IMPACT OF LOWER CAPITAL INVESTMENT IN SUTS OVER MULTI-USE PLATFORMS AND LESS FLOOR SPACE REQUIREMENTS
EXHIBIT 19 MAJOR ADVANTAGES OF INVESTING IN SINGLE-USE TECHNOLOGIES
EXHIBIT 20 IMPACT OF INCREASED ACCEPTANCE OF SUS TO ENHANCE BIOMANUFACTURING PRODUCTIVITY AND EFFICIENCY
EXHIBIT 21 IMPACT OF REDUCED WATER CONSUMPTION AND LESSER ENVIRONMENTAL IMPACT OF SINGLE-USE TECHNOLOGIES
EXHIBIT 22 WATER CONSUMPTION COMPARISON OF SINGLE-USE AND TRADITIONAL STAINLESS-STEEL SYSTEMS (IN LITERS)
EXHIBIT 23 IMPACT OF CHANGING SCALE OF SINGLE-USE OPERATIONS
EXHIBIT 24 IMPACT OF LOW STRENGTH OF SUPPLY CHAIN AND LACK OF STANDARDIZATION
EXHIBIT 25 IMPACT OF ISSUES RELATED TO LEACHABLES AND EXTRACTABLES
EXHIBIT 26 GLOBAL SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 27 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 28 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 29 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 30 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 31 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 32 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY: MARKET OPPORTUNITY OVERVIEW (2022 & 2028)
EXHIBIT 33 FIVE FORCES ANALYSIS (2022)
EXHIBIT 34 INCREMENTAL GROWTH BY PRODUCT TYPE (2022 & 2028)
EXHIBIT 35 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 36 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 37 GLOBAL SINGLE-USE BIOPROCESSING EQUIPMENT MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL SINGLE-USE BIOPROCESSING EQUIPMENT MARKET 2022–2028 ($ MILLION)
EXHIBIT 39 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 42 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 43 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 44 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 46 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 48 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 50 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 52 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 53 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 54 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 55 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 57 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 59 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY METHOD (2022 & 2028)
EXHIBIT 62 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 63 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD: ABSOLUTE GROWTH (%)
EXHIBIT 64 GLOBAL FILTRATION SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL FILTRATION SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 66 GLOBAL STORAGE & TRANSPORT SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL STORAGE & TRANSPORT SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 68 GLOBAL CELL CULTURE SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL CELL CULTURE SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 70 GLOBAL MIXING SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL MIXING SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 72 GLOBAL PURIFICATION SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL PURIFICATION SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 74 INCREMENTAL GROWTH BY WORKFLOW (2022 & 2028)
EXHIBIT 75 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 76 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW: ABSOLUTE GROWTH (%)
EXHIBIT 77 GLOBAL UPSTREAM SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 78 GLOBAL UPSTREAM SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 79 GLOBAL DOWNSTREAM SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL DOWNSTREAM SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY (2022 & 2028)
EXHIBIT 82 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 83 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 84 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET: KEY COUNTRIES BY REVENUE 2022 ($ MILLION)
EXHIBIT 86 SINGLE-USE BIOPROCESSING MARKET IN NORTH AMERICA 2022–2028 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA (2022 & 2028)
EXHIBIT 88 US SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 89 SINGLE-USE BIOPROCESSING MARKET IN CANADA 2022–2028 ($ MILLION)
EXHIBIT 90 SINGLE-USE BIOPROCESSING MARKET IN EUROPE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 SINGLE-USE BIOPROCESSING MARKET IN EUROPE: KEY COUNTRIES BY REVENUE 2022 ($ MILLION)
EXHIBIT 92 SINGLE-USE BIOPROCESSING MARKET IN EUROPE 2022–2028 ($ MILLION)
EXHIBIT 93 INCREMENTAL GROWTH IN EUROPE (2022 & 2028)
EXHIBIT 94 SINGLE-USE BIOPROCESSING MARKET IN GERMANY 2022–2028 ($ MILLION)
EXHIBIT 95 SINGLE-USE BIOPROCESSING MARKET IN FRANCE 2022–2028 ($ MILLION)
EXHIBIT 96 SINGLE-USE BIOPROCESSING MARKET IN SWITZERLAND 2022–2028 ($ MILLION)
EXHIBIT 97 UK SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 98 SINGLE-USE BIOPROCESSING MARKET IN ITALY 2022–2028 ($ MILLION)
EXHIBIT 99 SINGLE-USE BIOPROCESSING MARKET IN SPAIN 2022–2028 ($ MILLION)
EXHIBIT 100 APAC SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 101 APAC SINGLE-USE BIOPROCESSING MARKET: KEY COUNTRIES BY REVENUE 2022 ($ MILLION)
EXHIBIT 102 APAC SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 103 INCREMENTAL GROWTH IN APAC (2022 & 2028)
EXHIBIT 104 SINGLE-USE BIOPROCESSING MARKET IN CHINA 2022–2028 ($ MILLION)
EXHIBIT 105 SINGLE-USE BIOPROCESSING MARKET IN JAPAN 2022–2028 ($ MILLION)
EXHIBIT 106 SINGLE-USE BIOPROCESSING MARKET IN AUSTRALIA 2022–2028 ($ MILLION)
EXHIBIT 107 SINGLE-USE BIOPROCESSING MARKET IN SOUTH KOREA 2022–2028 ($ MILLION)
EXHIBIT 108 SINGLE-USE BIOPROCESSING MARKET IN INDIA 2022–2028 ($ MILLION)
EXHIBIT 109 SINGLE-USE BIOPROCESSING MARKET IN LATIN AMERICA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 SINGLE-USE BIOPROCESSING MARKET IN LATIN AMERICA: KEY COUNTRIES BY REVENUE 2022 ($ MILLION)
EXHIBIT 111 SINGLE-USE BIOPROCESSING MARKET IN LATIN AMERICA 2022–2028 ($ MILLION)
EXHIBIT 112 INCREMENTAL GROWTH IN LATIN AMERICA (2022 & 2028)
EXHIBIT 113 SINGLE-USE BIOPROCESSING MARKET IN BRAZIL 2022–2028 ($ MILLION)
EXHIBIT 114 SINGLE-USE BIOPROCESSING MARKET IN MEXICO 2022–2028 ($ MILLION)
EXHIBIT 115 SINGLE-USE BIOPROCESSING MARKET IN COLUMBIA 2022–2028 ($ MILLION)
EXHIBIT 116 SINGLE-USE BIOPROCESSING MARKET IN ARGENTINA 2022–2028 ($ MILLION)
EXHIBIT 117 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 118 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET: KEY COUNTRIES BY REVENUE 2022 ($ MILLION)
EXHIBIT 119 SINGLE-USE BIOPROCESSING MARKET IN MIDDLE EAST & AFRICA 2022–2028 ($ MILLION)
EXHIBIT 120 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2022 & 2028)
EXHIBIT 121 SINGLE-USE BIOPROCESSING MARKET IN TURKEY 2022–2028 ($ MILLION)
EXHIBIT 122 SINGLE-USE BIOPROCESSING MARKET IN SAUDI ARABIA 2022–2028 ($ MILLION)
EXHIBIT 123 UAE SINGLE-USE BIOPROCESSING MARKET 2022–2028 ($ MILLION)
EXHIBIT 124 SINGLE-USE BIOPROCESSING MARKET IN SOUTH AFRICA 2022–2028 ($ MILLION)
EXHIBIT 125 VENDORS OFFERING SINGLE-USE BIOPROCESSING EQUIPMENT: MARKET DOMINANCE ANALYSIS
EXHIBIT 126 VENDORS OFFERING COMMERCIAL SINGLE-USE BIOPROCESSING EQUIPMENT: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 127 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 128 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 129 THERMO FISHER SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 130 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHY 2022 ($ BILLION)
EXHIBIT 131 SARTORIUS STEDIM BIOTECH: TOTAL REVENUE 2020-2022 ($ BILLION)
EXHIBIT 132 SARTORIUS STEDIM BIOTECH: R&D EXPENDITURE 2020-2022 ($ BILLION)
EXHIBIT 133 DANAHER: TOTAL REVENUE 2020-2022 ($ BILLION)
EXHIBIT 134 DANAHER: R&D EXPENDITURE 2020-2022 ($ BILLION)
EXHIBIT 135 DANAHER: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 136 DANAHER: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 137 MERCK KGAA: TOTAL REVENUE 2020-2022 ($ BILLION)
EXHIBIT 138 MERCK KGAA: R&D EXPENDITURE 2020-2022 ($ BILLION)
EXHIBIT 139 MERCK KGAA: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 140 MERCK KGAA: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 141 AVANTOR: TOTAL REVENUE 2020-2022 ($ BILLION)
EXHIBIT 142 AVANTOR: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION (2016−2022)
TABLE 3 RECENT NEW PRODUCT LAUNCHES
TABLE 4 RECENT STRATEGIC ACQUISITIONS
TABLE 5 RECENT COLLABORATIONS
TABLE 6 COMPARISON: SINGLE-USE VS STAINLESS STEEL PLATFORM
TABLE 7 EXAMPLES OF RECENT INVESTMENTS IN SINGLE-USE TECHNOLOGY
TABLE 8 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT: MARKET SIZE (2022 & 2028)
TABLE 9 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION: MARKET SIZE (2022 & 2028)
TABLE 10 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER: MARKET SIZE (2022 & 2028)
TABLE 11 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD: MARKET SIZE (2022 & 2028)
TABLE 12 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW: MARKET SIZE (2022 & 2028)
TABLE 13 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY: MARKET SIZE (2022 & 2028)
TABLE 14 KEY DIFFERENCES: SINGLE-USE VS STAINLESS STEEL BIOREACTOR
TABLE 15 GLOBAL SINGLE-USE BIOPROCESSING MARKET EQUIPMENT BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 16 GLOBAL SINGLE-USE BIOPROCESSING MARKET EQUIPMENT BY GEOGRAPHY 2022−2028 (%)
TABLE 17 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 18 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 19 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 20 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 21 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 22 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 23 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 24 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 25 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 26 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 27 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 28 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 29 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 30 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 31 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 32 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 33 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 34 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 35 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 36 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 37 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 38 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 39 EUROPE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 40 EUROPE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 41 EUROPE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 42 EUROPE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 43 EUROPE SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 44 EUROPE SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 45 APAC SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 46 APAC SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 47 APAC SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 48 APAC SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 49 APAC SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 50 APAC SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 51 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 52 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 53 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 54 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 55 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 56 LATIN AMERICAN SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 57 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 58 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 59 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 60 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 61 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 62 MIDDLE EAST & AFRICAN SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 63 GLOBAL SINGLE-USE BIOPROCESSING MARKET: KEY VENDORS RANKING (2022)
TABLE 64 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 65 SARTORIUS STEDIM BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 66 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 67 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 68 AVANTOR: MAJOR PRODUCT OFFERINGS
TABLE 69 3I GROUP: MAJOR PRODUCT OFFERINGS
TABLE 70 3M: MAJOR PRODUCT OFFERINGS
TABLE 71 ABEC: MAJOR PRODUCT OFFERINGS
TABLE 72 ADOLF KÜHNER: MAJOR PRODUCT OFFERINGS
TABLE 73 ADVANTAPURE: MAJOR PRODUCT OFFERINGS
TABLE 74 BARRY-WEHMILLER COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 75 BROADLEY-JAMES: MAJOR PRODUCT OFFERINGS
TABLE 76 CELLTAINER BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 77 CERCELL A/S: MAJOR PRODUCT OFFERINGS
TABLE 78 CESCO BIOENGINEERING: MAJOR PRODUCT OFFERINGS
TABLE 79 CHARTER MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 80 COLDER PRODUCTS COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 81 CORNING: MAJOR PRODUCT OFFERINGS
TABLE 82 DISTEK: MAJOR PRODUCT OFFERINGS
TABLE 83 DRM, DR. MUELLER: MAJOR PRODUCT OFFERINGS
TABLE 84 EMERSON ELECTRIC: MAJOR PRODUCT OFFERINGS
TABLE 85 ENTEGRIS: MAJOR PRODUCT OFFERINGS
TABLE 86 EPPENDORF: MAJOR PRODUCT OFFERINGS
TABLE 87 FOXX LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 88 GETINGE: MAJOR PRODUCT OFFERINGS
TABLE 89 HIGH PURITY NEW ENGLAND: MAJOR PRODUCT OFFERINGS
TABLE 90 HOLAND APPLIED TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 91 LONZA: MAJOR PRODUCT OFFERINGS
TABLE 92 MEISSNER FILTRATION PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 93 NEW HORIZON BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 94 OMNIBRX BIOTECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 95 PARKER HANNIFIN: MAJOR PRODUCT OFFERINGS
TABLE 96 PENDOTECH: MAJOR PRODUCT OFFERINGS
TABLE 97 PBS BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 98 REPLIGEN: MAJOR PRODUCT OFFERINGS
TABLE 99 SAINT-GOBAIN: MAJOR PRODUCT OFFERINGS
TABLE 100 SENTINEL PROCESS SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 101 SOLARIS BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 102 SYSBIOTECH GMBH: MAJOR PRODUCT OFFERINGS
TABLE 103 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 104 WEIGAO GROUP: MAJOR PRODUCT OFFERINGS
TABLE 105 W.L. GORE & ASSOCIATES: MAJOR PRODUCT OFFERINGS
TABLE 106 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 107 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 108 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 109 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 110 EUROPE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 111 EUROPE SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 112 APAC SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 113 APAC SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 114 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 115 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 116 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 ($ MILLION)
TABLE 117 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY PRODUCT TYPE 2022−2028 (%)
TABLE 118 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 119 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 120 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 121 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 122 EUROPE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 123 EUROPE SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 124 APAC SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 125 APAC SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 126 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 127 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 128 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 129 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY APPLICATION 2022−2028 (%)
TABLE 130 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 131 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 132 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 133 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 134 EUROPE SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 135 EUROPE SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 136 APAC SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 137 APAC SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 138 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 139 LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 140 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 141 MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET BY END-USER 2022−2028 (%)
TABLE 142 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD 2022−2028 ($ MILLION)
TABLE 143 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY METHOD 2022−2028 (%)
TABLE 144 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW 2022−2028 ($ MILLION)
TABLE 145 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY WORKFLOW 2022−2028 (%)
TABLE 146 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 147 GLOBAL SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 148 GLOBAL SINGLE-USE BIOPROCESSING MARKET EQUIPMENT BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 149 GLOBAL SINGLE-USE BIOPROCESSING MARKET EQUIPMENT BY GEOGRAPHY 2022−2028 (%)
TABLE 150 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 151 GLOBAL SIMPLE & PERIPHERAL DEVICES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 152 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 153 GLOBAL MONOCLONAL ANTIBODIES (MABS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 154 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 155 GLOBAL VACCINES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 156 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 157 GLOBAL CELL THERAPIES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 158 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 159 GLOBAL OTHERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 160 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 161 GLOBAL BIOPHARMACEUTICAL MANUFACTURERS SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 162 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 163 GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 164 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 165 GLOBAL R&D COMPANIES AND RESEARCH INSTITUTES SINGLE-USE BIOPROCESSING MARKET BY GEOGRAPHY 2022−2028 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USERS
4.3.4 MARKET SEGMENTATION BY METHOD
4.3.5 MARKET SEGMENTATION BY WORKFLOW
4.3.6 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 MARKET OVERVIEW
6.1.1 GEOGRAPHY INSIGHTS
6.1.2 PRODUCT TYPE INSIGHTS
6.1.3 APPLICATION INSIGHTS
6.1.4 END-USER INSIGHTS
6.1.5 METHOD INSIGHTS
6.1.6 WORKFLOW INSIGHTS
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 SINGLE-USE TECHNOLOGY IN CELL AND GENE THERAPY
9.2 INCREASING DEMAND FOR CONTINUOUS BIOPROCESSING
9.3 TECHNOLOGICAL ADVANCES IN SINGLE-USE BIOPROCESSING (SUB)
9.4 NEW PRODUCT LAUNCHES
9.5 INCREASING STRATEGIC ACQUISITIONS AND COLLABORATIONS
10 MARKET GROWTH ENABLERS
10.1 GROWING BIOMANUFACTURING CAPACITY AND UPTAKE OF BIOPHARMACEUTICALS & BIOSIMILARS
10.2 LOWER CAPITAL INVESTMENT IN SUTS OVER MULTI-USE PLATFORMS AND LESS FLOOR SPACE REQUIREMENTS
10.3 INCREASED ACCEPTANCE OF SUS TO ENHANCE BIOMANUFACTURING PRODUCTIVITY AND EFFICIENCY
10.4 REDUCED WATER CONSUMPTION AND LESSER ENVIRONMENTAL IMPACT OF SINGLE-USE TECHNOLOGIES
11 MARKET RESTRAINTS
11.1 THE CHANGING SCALE OF SINGLE-USE OPERATIONS
11.2 LOW STRENGTH OF SUPPLY CHAIN AND LACK OF STANDARDIZATION
11.3 ISSUES RELATED TO LEACHABLES AND EXTRACTABLES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 MARKET OPPORTUNITY
12.3.1 MARKET BY PRODUCT
12.3.2 MARKET BY APPLICATION
12.3.3 MARKET BY END-USER
12.3.4 MARKET BY METHOD
12.3.5 MARKET BY WORKFLOW
12.3.6 MARKET BY GEOGRAPHY
12.4 FIVE FORCES ANALYSIS
12.4.1 THREAT OF NEW ENTRANTS
12.4.2 BARGAINING POWER OF SUPPLIERS
12.4.3 BARGAINING POWER OF BUYERS
12.4.4 THREAT OF SUBSTITUTES
12.4.5 COMPETITIVE RIVALRY
13 PRODUCT TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SINGLE-USE BIOPROCESSING EQUIPMENT
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
13.4 SIMPLE & PERIPHERAL DEVICES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MONOCLONAL ANTIBODIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
14.4 VACCINES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 VACCINES MARKET BY GEOGRAPHY
14.5 CELL THERAPIES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 CELL THERAPIES MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHERS MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 BIOPHARMACEUTICAL MANUFACTURERS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
15.4 CONTRACT MANUFACTURING ORGANIZATIONS (CMO)
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
15.5 R&D COMPANIES AND RESEARCH INSTITUTES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY
16 METHOD
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 FILTRATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 STORAGE & TRANSPORT
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 CELL CULTURE
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 MIXING
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 PURIFICATION
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
17 WORKFLOW
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 MARKET OVERVIEW
17.3 UPSTREAM
17.3.1 MARKET OVERVIEW
17.3.2 MARKET SIZE & FORECAST
17.4 DOWNSTREAM
17.4.1 MARKET OVERVIEW
17.4.2 MARKET SIZE & FORECAST
18 GEOGRAPHY
18.1 MARKET SNAPSHOT & GROWTH ENGINE
18.2 GEOGRAPHIC OVERVIEW
19 NORTH AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
19.2.2 NORTH AMERICA MARKET BY APPLICATION
19.2.3 NORTH AMERICA MARKET BY END-USER
19.3 KEY COUNTRIES
19.3.1 US: MARKET SIZE & FORECAST
19.3.2 CANADA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 EUROPE MARKET BY PRODUCT TYPE
20.2.2 EUROPE MARKET BY APPLICATION
20.2.3 EUROPE MARKET BY END-USER
20.3 KEY COUNTRIES
20.3.1 GERMANY: MARKET SIZE & FORECAST
20.3.2 FRANCE: MARKET SIZE & FORECAST
20.3.3 SWITZERLAND: MARKET SIZE & FORECAST
20.3.4 UK: MARKET SIZE & FORECAST
20.3.5 ITALY: MARKET SIZE & FORECAST
20.3.6 SPAIN: MARKET SIZE & FORECAST
21 APAC
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 APAC MARKET BY PRODUCT TYPE
21.2.2 APAC MARKET BY APPLICATION
21.2.3 APAC MARKET BY END-USER
21.3 KEY COUNTRIES
21.3.1 CHINA: MARKET SIZE & FORECAST
21.3.2 JAPAN: MARKET SIZE & FORECAST
21.3.3 AUSTRALIA: MARKET SIZE & FORECAST
21.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
21.3.5 INDIA: MARKET SIZE & FORECAST
22 LATIN AMERICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
22.2.2 LATIN AMERICA MARKET BY APPLICATION
22.2.3 LATIN AMERICA MARKET BY END-USER
22.3 KEY COUNTRIES
22.3.1 BRAZIL: MARKET SIZE & FORECAST
22.3.2 MEXICO: MARKET SIZE & FORECAST
22.3.3 COLOMBIA: MARKET SIZE & FORECAST
22.3.4 ARGENTINA: MARKET SIZE & FORECAST
23 MIDDLE EAST & AFRICA
23.1 MARKET OVERVIEW
23.2 MARKET SIZE & FORECAST
23.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
23.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
23.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
23.3 KEY COUNTRIES
23.3.1 TURKEY: MARKET SIZE & FORECAST
23.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
23.3.3 UAE: MARKET SIZE & FORECAST
23.3.4 SOUTH AFRICA: MARKET SIZE & FORECAST
24 COMPETITIVE LANDSCAPE
24.1 COMPETITION OVERVIEW
24.1.1 VENDOR ACTIVITIES IN SINGLE-USE BIOPROCESSING MARKET
24.2 MARKET SHARE ANALYSIS
24.2.1 THERMO FISHER SCIENTIFIC
24.2.2 SARTORIUS STEDIM BIOTECH
24.2.3 DANAHER
24.2.4 MERCK KGAA
24.2.5 AVANTOR
25 KEY COMPANY PROFILES
25.1 THERMO FISHER SCIENTIFIC
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.1.3 KEY STRATEGIES
25.1.4 KEY STRENGTHS
25.1.5 KEY OPPORTUNITIES
25.2 SARTORIUS STEDIM BIOTECH
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.2.3 KEY STRATEGIES
25.2.4 KEY STRENGTHS
25.2.5 KEY OPPORTUNITIES
25.3 DANAHER
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.3.3 KEY STRATEGIES
25.3.4 KEY STRENGTHS
25.3.5 KEY OPPORTUNITIES
25.4 MERCK KGAA
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.4.3 KEY STRATEGIES
25.4.4 KEY STRENGTHS
25.4.5 KEY OPPORTUNITIES
25.5 AVANTOR
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.5.3 KEY STRATEGIES
25.5.4 KEY STRENGTHS
25.5.5 KEY OPPORTUNITIES
26 OTHER PROMINENT VENDORS
26.1 3I GROUP
26.1.1 BUSINESS OVERVIEW
26.1.2 PRODUCT OFFERINGS
26.2 3M
26.2.1 BUSINESS OVERVIEW
26.2.2 PRODUCT OFFERINGS
26.3 ABEC
26.3.1 BUSINESS OVERVIEW
26.3.2 PRODUCT OFFERINGS
26.4 ADOLF KÜHNER
26.4.1 BUSINESS OVERVIEW
26.4.2 PRODUCT OFFERINGS
26.5 ADVANTAPURE
26.5.1 BUSINESS OVERVIEW
26.5.2 PRODUCT OFFERINGS
26.6 BARRY-WEHMILLER COMPANIES
26.6.1 BUSINESS OVERVIEW
26.6.2 PRODUCT OFFERING
26.7 BROADLEY-JAMES
26.7.1 BUSINESS OVERVIEW
26.7.2 PRODUCT OFFERINGS
26.8 CELLTAINER BIOTECH
26.8.1 BUSINESS OVERVIEW
26.8.2 PRODUCT OFFERINGS
26.9 CERCELL A/S
26.9.1 BUSINESS OVERVIEW
26.9.2 PRODUCT OFFERINGS
26.10 CESCO BIOENGINEERING
26.10.1 BUSINESS OVERVIEW
26.10.2 PRODUCT OFFERINGS
26.11 CHARTER MEDICAL
26.11.1 BUSINESS OVERVIEW
26.11.2 PRODUCT OFFERINGS
26.12 COLDER PRODUCTS COMPANY
26.12.1 BUSINESS OVERVIEW
26.12.2 PRODUCT OFFERINGS
26.13 CORNING
26.13.1 BUSINESS OVERVIEW
26.13.2 PRODUCT OFFERINGS
26.14 DISTEK
26.14.1 BUSINESS OVERVIEW
26.14.2 PRODUCT OFFERINGS
26.15 DRM, DR. MUELLER
26.15.1 BUSINESS OVERVIEW
26.15.2 PRODUCT OFFERINGS
26.16 EMERSON ELECTRIC
26.16.1 BUSINESS OVERVIEW
26.16.2 PRODUCT OFFERINGS
26.17 ENTEGRIS
26.17.1 BUSINESS OVERVIEW
26.17.2 PRODUCT OFFERINGS
26.18 EPPENDORF
26.18.1 BUSINESS OVERVIEW
26.18.2 PRODUCT OFFERINGS
26.19 FOXX LIFE SCIENCES
26.19.1 BUSINESS OVERVIEW
26.19.2 PRODUCT OFFERINGS
26.20 GETINGE
26.20.1 BUSINESS OVERVIEW
26.20.2 PRODUCT OFFERINGS
26.21 HIGH-PURITY NEW ENGLAND
26.21.1 BUSINESS OVERVIEW
26.21.2 PRODUCT OFFERINGS
26.22 HOLLAND APPLIED TECHNOLOGIES
26.22.1 BUSINESS OVERVIEW
26.22.2 PRODUCT OFFERINGS
26.23 LONZA
26.23.1 BUSINESS OVERVIEW
26.23.2 PRODUCT OFFERINGS
26.24 MEISSNER FILTRATION PRODUCTS
26.24.1 BUSINESS OVERVIEW
26.24.2 PRODUCT OFFERINGS
26.25 NEW HORIZON BIOTECH
26.25.1 BUSINESS OVERVIEW
26.25.2 PRODUCT OFFERINGS
26.26 OMNIBRX BIOTECHNOLOGIES
26.26.1 BUSINESS OVERVIEW
26.26.2 PRODUCT OFFERINGS
26.27 PARKER HANNIFIN
26.27.1 BUSINESS OVERVIEW
26.27.2 PRODUCT OFFERINGS
26.28 PENDOTECH
26.28.1 BUSINESS OVERVIEW
26.28.2 PRODUCT OFFERINGS
26.29 PBS BIOTECH
26.29.1 BUSINESS OVERVIEW
26.29.2 PRODUCT OFFERINGS
26.30 REPLIGEN
26.30.1 BUSINESS OVERVIEW
26.30.2 PRODUCT OFFERINGS
26.31 SAINT-GOBAIN
26.31.1 BUSINESS OVERVIEW
26.31.2 PRODUCT OFFERINGS
26.32 SENTINEL PROCESS SYSTEMS
26.32.1 BUSINESS OVERVIEW
26.32.2 PRODUCT OFFERINGS
26.33 SOLARIS BIOTECHNOLOGY
26.33.1 BUSINESS OVERVIEW
26.33.2 PRODUCT OFFERINGS
26.34 SYSBIOTECH
26.34.1 BUSINESS OVERVIEW
26.34.2 PRODUCT OFFERINGS
26.35 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
26.35.1 BUSINESS OVERVIEW
26.35.2 PRODUCT OFFERINGS
26.36 WEIGAO GROUP
26.36.1 BUSINESS OVERVIEW
26.36.2 PRODUCT OFFERINGS
26.37 W.L. GORE & ASSOCIATES
26.37.1 BUSINESS OVERVIEW
26.37.2 PRODUCT OFFERINGS
27 REPORT SUMMARY
27.1 KEY TAKEAWAYS
27.2 STRATEGIC RECOMMENDATIONS
28 QUANTITATIVE SUMMARY
28.1 MARKET BY PRODUCT TYPE
28.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
28.1.2 EUROPE MARKET BY PRODUCT TYPE
28.1.3 APAC MARKET BY PRODUCT TYPE
28.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
28.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
28.2 MARKET BY APPLICATION
28.2.1 NORTH AMERICA MARKET BY APPLICATION
28.2.2 EUROPE MARKET BY APPLICATION
28.2.3 APAC MARKET BY APPLICATION
28.2.4 LATIN AMERICA MARKET BY APPLICATION
28.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
28.3 MARKET BY END-USER
28.3.1 NORTH AMERICA MARKET BY END-USER
28.3.2 EUROPE MARKET BY END-USER
28.3.3 APAC MARKET BY END-USER
28.3.4 LATIN AMERICA MARKET BY END-USER
28.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
28.4 MARKET BY METHOD
28.5 MARKET BY WORKFLOW
28.6 MARKET BY GEOGRAPHY
28.6.1 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
28.6.2 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
28.6.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
28.6.4 VACCINES MARKET BY GEOGRAPHY
28.6.5 CELL THERAPIES MARKET BY GEOGRAPHY
28.6.6 OTHERS MARKET BY GEOGRAPHY
28.6.7 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
28.6.8 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
28.6.9 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY
29 APPENDIX
29.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global single-use bioprocessing market?
What is the growth rate of the single-use bioprocessing market?
What are the rising trends in the single-use bioprocessing market?
Which region holds the most significant global single-use bioprocessing market share?
Who are the key players in the global single-use bioprocessing market?
Other RELATED Reports
Surgical Wound Closure Devices Market - Global Outlook and Forecast 2021-2026
Published : February 2021
Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026
Published : April 2021
Single-Use Bioprocessing Probes And Sensors Market - Global Outlook & Forecast 2022-2027
Published : June 2022
Biopharmaceutical Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
Published : August 2022